key: cord-0844438-4r25eh0c
authors: Konstantinidou, A. E.; Angelidou, S.; Havaki, S.; Paparizou, K.; Spanakis, N.; Chatzakis, C.; Sotiriadis, A.; Theodora, M.; Donoudis, C.; Daponte, A.; Skaltsounis, P.; Gorgoulis, V.; Papaevangelou, V.; Kalantaridou, S.; Tsakris, A.
title: Stillbirth due to SARS‐CoV‐2 placentitis without evidence of intrauterine transmission to fetus: association with maternal risk factors
date: 2022-03-30
journal: Ultrasound Obstet Gynecol
DOI: 10.1002/uog.24906
sha: f7c1552fcb984d9fb6a363215017cb0480c5a178
doc_id: 844438
cord_uid: 4r25eh0c

OBJECTIVES: To report the causative relationship of maternal COVID‐19 with intrauterine fetal death, describe the specific placental pathology, findings of fetal autopsy and clinical characteristics, and identify potential risk factors. METHODS: This is a prospective case series. A cohort of 165 placentas of non‐vaccinated pregnant women affected by COVID‐19 in Greece were histologically examined and six cases of intrauterine fetal death associated with SARS‐COV‐2 placentitis were retrieved. Complete fetal autopsy was performed in three cases. Gross, histopathological, immunohistochemical, molecular, and electron microscopy examinations were carried out in the stillbirth placentas and fetal organs. The histological findings of SARS‐COV‐2 placentitis were compared with the 159 cases, in which maternal COVID‐19 resulted in livebirth. Regression analysis was used to identify predisposing factors for SARS‐COV‐2 placentitis. RESULTS: All six stillbirth placentas showed severe and extensive histological changes of SARS‐COV‐2 placentitis, i.e. a combination of marked intervillositis with a mixed inflammatory infiltrate and massive perivillous fibrinoid deposition with trophoblast damage, associated with intensely positive immunostaining for SARS‐COV‐2 spike protein, the presence of virions on electron microscopy and a positive RT‐PCR test in placental tissues. The histological lesions obliterated over 75% of the maternal intervillous space, accounting for intrauterine fetal death. Similar histological lesions affecting less than 25% of the placenta were recorded in 7 liveborn neonates, while the remaining 152 placentas of COVID‐19‐affected pregnancies with livebirths did not show similar findings. Complete fetal autopsy showed evidence of an asphyctic mode of death without evidence of viral transmission to the fetus. The mothers had mild clinical symptoms or were asymptomatic and the interval between maternal COVID‐19 diagnosis and fetal death ranged from 3 to 15 days. Statistically significant predisposing factors for SARS‐COV‐2‐placentitis included thrombophilia and IUGR. Multiple sclerosis was seen in one case. CONCLUSIONS: SARS‐COV‐2 placentits occurred uncommonly in COVID‐19‐affected pregnancies of non‐vaccinated mothers and, when extensive, caused fetal demise, with no evidence of transplacental fetal infection. Thrombophilia and prenatally detected IUGR emerged as independent predisposing factors for the potentially lethal SARS‐COV‐2 placentitis. This article is protected by copyright. All rights reserved.

The COVID-19 global pandemic has raised, among many others, major concerns regarding the impact of infection on pregnancy course, resulting in regular updates of guidances and recommendations, based on emerging evidence and epidemiological studies.

Intrauterine transplacental transmission of SARS-COV-2 from mother to fetus is thought to occur, typically via a hematogenous route, but is uncommon 1, 2 . Most placentas studied had no evidence of infection, and of those tested, a minority tested positive for SARS-COV-2 genome (7.7 -21%) 3, 4 . As the COVID-19 pandemic evolved during 2020, a small number of international reports began to emerge describing a particular pattern of inflammation in placentas of COVID-19 positive women, which was termed "SARS-COV-2 placentitis" in January 2021 5 . Placental involvement with SARS-COV-2 placentitis seemed to be uncommon, but had the potential to cause significant placental injury, potentially resulting in fetal compromise.

In this study we report six cases of intrauterine fetal death (IUFD) in Greece attributed to SARS-COV-2 placentitis, retrieved from a cohort of 165 COVID-affected pregnancies, describe the specific placental pathology and ancillary tests, the findings of fetal autopsy, compare with the histological findings in livebirths, and identify potential risk factors.

This is a prospective multicenter study, designed and supervised by the 3 rd Clinic of Pediatrics, Attikon University Hospital, and the Unit of Perinatal Pathology, 1 st Department of Pathology, Medical School, National and Kapodistrian University of Athens (NKUA), Greece.

In the context of this study, from April 18, 2020 until August 31, 2021 a total of 165 placentas of COVID-19-affected pregnant women were sent for histological examination at the Units of Perinatal Pathology, University Laboratories of Pathology, Medical School NKUA, Athens, and the Laboratory of Pathology, Hippokration Hospital, Thessaloniki, both referral centers for perinatal and placental pathology in Greece. All women gave their informed consent for the examination of the placentas, and the study was approved by the Ethical Committee of Attikon University Hospital, Medical School, NKUA.

During the study period, six COVID-affected pregnancies were complicated with IUFD, and the parents opted for full fetal autopsy in three. The remaining 159 pregnancies resulted in livebirth. Clinical characteristics of the pregnancies, including maternal history, were available in 69 cases.

All six IUFDs occurred in 6 different towns across Greece, between December 2020 and August 2021. Clinical information is shown in Mother #2 was lost to follow-up. In this case, prenatal ultrasound monitoring before maternal COVID had shown oligohydramnios and abnormal Doppler, while in the remaining five cases, prenatal findings were normal (Table 1 ). Decreased fetal movements were recorded in 3 cases post-infection.

The following investigations were carried out in the placentas:

On admission at the pathology laboratory, four of six IUFD placentas were sampled fresh for RT-PCR-testing, using protective equipment, two were received in formalin and were not sampled. The fetal surface was cleaned with alcohol solution to minimize the possibility of viral RNA contamination from traces of maternal blood, amniotic fluid or other maternal fluids, and a section of 1cm was cut with a sterile blade from the placental parenchyma. Fresh tissue samples were also obtained from the lungs, liver, and spleen of two autopsied fetuses. Samples were delivered to the University Department of Microbiology, Medical School NKUA, Athens, and were tested for the presence of viral RNA using the genesig Real-Time PCR COVID-19 assay Electron Microscopy: Four IUFD placentas were processed for electron microscopy after previous fixation in formalin. Small tissue fragments (1-2mm3) from each placenta were cut and washed with dΗ20 5min (x3) and re-fixed in 2.5% glutaraldehyde in PBS for 2h at RT and then overnight at 4oC. After washing with PBS, the specimens were post-fixed in 1% aqueous osmium tetroxide for 1h at 4oC, then dehydrated in a graded series of ethyl alcohol, followed by propylene oxide (PO), infiltrated gradually in a mixture of Epon/Araldite resins diluted in PO and finally embedded in fresh epoxy resin mixture. Ultrathin epoxy sections (70-80nm thickness) were cut on a Leica Ultracut R ultramicrotome, equipped with a Diatome diamond knife and observed with a FEI Morgagni 268 transmission electron microscope equipped with Olympus Morada digital camera. 

One placenta (case #2) was small, the weight falling under the 10 th centile, the remaining five were appropriately grown for age. On gross examination and cut sections, all six placentas were compact and stiff, with a mosaic pattern of whitish streaks running through the parenchyma and intervening hemorrhagic lesions (Fig. 1 ). This process indicated massive perivillous fibrinoid deposition and involved over 75% of the placental parenchyma.

Histologically these lesions corresponded to a combination of massive perivillous fibrinoid deposition with severe diffuse intervillositis and intervillous thrombosis (Fig. 2) . The Table 2 .

The Alpha B117 variant of SARS-COV-2 was detected in the four tested stillbirth placentas with low cycle threshold (Ct < 20), in favor of high levels of genomic RNA.

Samples from the fetal organs, lungs, liver and spleen, were negative for SARS-COV-2 genome. PCR tests on fresh placental and fetal samples were negative for all other viruses tested (CMV, HSV1 and 2, Parvovirus, Enterovirus, and EBV).

PCR tests on formalin-fixed samples obtained from 16 livebirth-placentas with parenchymal inflammatory lesions were negative for other viruses (CMV, HSV1/2, ParvoB19, EBV).

Electron microscopy of the placental tissues revealed viral particles morphologically consistent with coronavirus. They were mostly observed within the cytoplasm of syncytiotrophoblast cells, either grouped within enlarged vesicles (Fig. 5 , Ai and Aii) or as single particles (Fig. 5B) . On higher magnification the virions showed faint surface projections, with the helical nucleocapsid appearing as internal black dots (Fig. 5B) .

Occasional virions were also identified within the basement membrane (BM) of the syncytiotrophoblasts bordering the intravillous space (Fig. 5C) . No virions were found on E/M in samples obtained from the lungs, liver and spleen of the autopsied fetuses.

Full postmortem examination of three fetuses was performed in case #3 (35 week-gestation) case #4 (27 +2 w) and case #6 (21 +1 w) ( Table 1 ). The fetuses were appropriately grown for age, weighing 2480g (42 nd centile), 1090g (44 th centile) and 397g (54 th centile) respectively.

There was evidence of an asphyctic mode of death, with pulmonary petechiae, meconium aspiration and visceral hemorrhages, without any histological evidence suggestive of infection. The brain of stillborn #3 showed focal subarachnoid hemorrhage with no evidence of hypoxic/ischaemic neuronal injury.

Out of 165 histologically examined placentas, clinical data entering the statistical analysis were available in 69 cases. Potential risk factors are presented in Table 3 

With regard to fetal death, initial evidence obtained from meta-analyses covering the first phases of the pandemic was reassuring that, despite the globally increasing number of COVID-19 infections, there was no significant increase of adverse pregnancy outcomes.

Data obtained at the subsequent phases of the pandemic, however, pointed towards an increase in the rates of fetal death, preterm birth, preeclampsia, and emergency cesarean delivery 6-8

The spectrum of placental histopathology in COVID-19-affected pregnancies is reportedly wide with variable, overall non-specific findings, generally related to uninfected neonates and a favorable pregnancy outcome 3, 9 . SARS-COV-2 placentitis", a particular pattern of placental pathology, appeared to emerge as the pandemic evolved during 2020, related to PCR-positive placentas and/or infected neonates [10] [11] [12] [13] , attributed to the Alpha variant in 2021 5 , and currently becoming more widely adopted in association with stillbirth 14 .

Our observations in the 6 herein reported cases of IUFD, occurring between December 2020 and August 2021, a period of prevalence of the Alpha B117 variant in Greece, confirm the detrimental potential of -at least-the Alpha variant on the placenta, causing in certain cases SARS-COV-2-placentitis, a constellation of severe histological lesions, potentially lethal when the placenta is diffusely affected. The lesions of SARS-COV-2-placentitis were identical in all six IUFDs, and were rapidly progressive, producing extensive occlusion of the intervillous space and compromising the maternal-fetal exchange. In our series, SARS-COV-2 placentitis consisted of a combination of massive perivillous fibrinoid deposition (MPFD), severe intervillositis with a mixed inflammatory infiltrate, trophoblast damage and intervillous thrombosis. This histology appears to differentiate SARS-COV-2 placentitis from the so far described COVID-associated "chronic histiocytic intervillositis" 5, 10, 11, 14 , due to the mixed component -histiocytic, lymphocytic and granulocytic-of the inflammatory populations, which is more consistent with an infectious etiology. Nevertheless, the combination of a predominantly mononuclear inflammation with MPFD in the placenta is not unique for SARS-COV-2, having been reported also in the context of other infectious etiology, e.g. cytomegalovirus and malaria 15, 16 .

The detection of virions within the cytoplasm and the basal membrane of perivillous syncytiotrophoblasts, suggests that the virus proceeded halfway within the placental barrier, but failed to enter the fetoplacental circulation. These observations underscore the crucial role of the perivillous syncytiotrophoblast as a key component of the placental barrier, but also demonstrate that at least the Alpha variant could cause fetal death by placental injury, without being transmitted to the fetus. These are further supported by the absence of any evidence of viral transmission in our 3 cases of autopsied fetuses, confirming that in these cases the virus failed to cross the placental barrier, but caused fetal death by asphyxia due to the diffuse occlusion of the intervillous space and the hypermetabolic inflammatory condition of the placenta, both compromising the fetomaternal exchange. This experience is not confined to Greece, and internationally a number of stillbirths have been attributed to SARS-COV-2 placentitis, continuing to occur during the period of prevalence of the Delta variant. 14, 17, 18 .

As, the occurrence of SARS-COV-2 placentitis seemed to be uncommon among COVID-19affected pregnancies, in accordance with other studies 19 , with no obvious correlation between its occurrence and the severity of maternal disease, the question was raised on the potential contribution of predisposing factors. Four of the six mothers of the presented IUFD cases with SARS-COV-2 placentitis, and four of the five mothers with livebirth and less extensive SARS-COV-2 placentits -and available clinical information, had underlying conditions associated with pregnancy complications, namely multiple sclerosis, an autoimmune disease associated with an increased risk of infections 20 , gestational diabetes, commonly associated with adverse pregnancy outcomes, thrombophilia factors, hypertension, and prenatally detected IUGR. Statistical analysis failed to confirm gestational/maternal diabetes as a significant predisposing factor for SARS-COV-2-placentitis, but was significant for thrombophilia and IUGR. Two mothers had homozygous or compound heterozygous polymorphisms for the PAI-1 and MTHFR genes, associated with abnormal coagulation or impaired fibrinolysis, considered as mild thrombophilias of uncertain clinical significance with regard to adverse pregnancy outcomes. It is of note though, that immune-mediated diseases and thrombophilias have been associated with MPFD, a rare and poorly understood placental disorder 21, 22 , which was one of the main components of SARS-COV-2 placentitis seen in all the IUFD cases, and to a lesser extent in 7 livebirths. In this context, given that coagulation and fibrinolysis abnormalities are common among COVID-19 patients 23 

At the time of this writing, the Alpha and Delta variants have been widely replaced globally, and as this disease and our experience continue to evolve, it is essential to highlight the importance of the pathological investigation of fetal death and its provision of information critical for the management of pregnancy during the COVID-19 pandemic. Further pathological and epidemiological investigations appear even more important, as the impact of novel globally spreading SARS-COV-2 variants is still unknown, this challenge remaining to be confronted in the immediate future. 

Vertical transmission of coronavirus disease 2019: a systematic review and metaanalysis

Rates of maternal and perinatal mortality and vertical transmission in pregnancies complicated by severe acute respiratory syndrome coronavirus 2 (SARS-Co-V-2) infection

A structured review of 343 placental morphology and histopathological lesions associated with SARS-COV-2 infection

Incidence of SARS-COV-2 vertical transmission: a meta-analysis

SARS-COV-2 placentitis: An uncommon complication of maternal COVID-19

Maternal and perinatal outcomes of pregnant women with SARS-COV-2 infection at the time of birth in England: national cohort study

Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study

Clinical symptoms associated with laboratory findings and placental histopathology in full-term, non-infected neonates born to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive mothers

Chronic Histiocytic Intervillositis With Trophoblast Necrosis Is a Risk Factor Associated With Placental Infection From Coronavirus Disease 2019 (COVID-19) and Intrauterine Maternal-Fetal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in Live-Born and Stillborn Infants

Transplacental transmission of SARS-COV-2 infection

Analysis of SARS-CoV-2 vertical transmission during pregnancy

Trophoblast damage with acute and chronic intervillositis: disruption of the placental barrier by severe acute respiratory syndrome coronavirus 2

Placental Tissue Destruction and Insufficiency from COVID-19 Causes Stillbirth and Neonatal Death from Hypoxic-Ischemic Injury: A Study of 68 Cases with SARS-CoV-2 Placentitis from 12 Countries

Combined Placental Maternal Floor Infarction and Cytomegalovirus Placentitis: A Case Report

Epub ahead of print

Massive chronic intervillositis of the placenta associated with malaria infection

/ Paediatric and Perinatal Pathology -SS-12 and OFP-21

Symposium: Covid experience, and Oral Communications

Infrequent Placental and Fetal Involvement in SARS-CoV-2 Infection: Pathology Data from a Large Medical Center

Pregnancy Outcomes in Women with Multiple Sclerosis

Maternal thrombophilias are associated with specific placental lesions

Clinicopathological characteristics of miscarriages featuring placental massive perivillous fibrin deposition

Abnormal Fibrinogen Level as a Prognostic Indicator in Coronavirus Disease Patients: A Retrospective Cohort Study